+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Medulloblastoma - Pipeline Insight, 2024 - Product Thumbnail Image

Medulloblastoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Medullary Thyroid Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Medullary Thyroid Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
From
Neuroblastoma - Pipeline Insight, 2024 - Product Thumbnail Image

Neuroblastoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Nasopharyngeal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Nasopharyngeal Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Myelofibrosis - Pipeline Insight, 2024 - Product Thumbnail Image

Myelofibrosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Mycosis Fungoides - Pipeline Insight, 2024 - Product Thumbnail Image

Mycosis Fungoides - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Papillary Thyroid Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Papillary Thyroid Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Pancreatic Endocrine Tumor - Pipeline Insight, 2024 - Product Thumbnail Image

Pancreatic Endocrine Tumor - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Pancreatic Ductal Adenocarcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Pancreatic Ductal Adenocarcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 200 Pages
  • Global
From
Osteosarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Osteosarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Malignant Mesothelioma - Pipeline Insight, 2024 - Product Thumbnail Image

Malignant Mesothelioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 110 Pages
  • Global
From
Kaposi's sarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Kaposi's sarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Thymus Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Thymus Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Liposarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Liposarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Vulvar Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Vulvar Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 70 Pages
  • Global
From
Anaplastic Thyroid Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Anaplastic Thyroid Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Actinic keratosis - Pipeline Insight, 2024 - Product Thumbnail Image

Actinic keratosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Chondrosarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Chondrosarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Insight, 2024 - Product Thumbnail Image

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more